Growth Metrics

OmniAb (OABI) Net Margin (2022 - 2026)

OmniAb (OABI) reported Net Margin of 53.42% for Q1 2026, up 38471.0% year-over-year from N/an in Q1 2025, and up 68.44% on a QoQ basis from 169.28% in Q4 2025.

OmniAb (OABI) has 5 years of Net Margin data on file, last reported at 53.42% in Q1 2026.

  • Quarterly Net Margin rose 38471.0% year-over-year to 53.42% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 187.59% (up 4152.0% YoY) and the FY2025 annual result came in at 347.04%, down 11199.0% from the prior year.
  • Net Margin improved to 53.42% in Q1 2026 per OABI's latest filing, from 169.28% in the prior quarter.
  • Across five years, Net Margin topped out at 19.3% in Q4 2022 and bottomed at 738.05% in Q3 2025.
  • The 5-year median for Net Margin is 179.03% (2024), against an average of 227.56%.
  • The widest annual swing landed in 2024, when Net Margin plunged 46279 bps; it then jumped 38471 bps in 2026.
  • Tracing OABI's Net Margin over 5 years: stood at 19.3% in 2022, then plunged by 1610 bps to 291.44% in 2023, then surged by 58 bps to 120.96% in 2024, then tumbled by 40 bps to 169.28% in 2025, then jumped by 68 bps to 53.42% in 2026.
  • Per Business Quant, the three latest OABI Net Margin figures stand at 53.42% (Q1 2026), 169.28% (Q4 2025), and 738.05% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 0.82%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 34.53%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 20.17%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 17.65%
10 OmniAb 334.72 Mn 291.75 Mn 14.41 Mn -53.42%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -53.42%
Dec 31, 2025 -169.28%
Sep 30, 2025 -738.05%
Jun 30, 2025 -407.36%
Mar 31, 2025 -438.13%
Dec 31, 2024 -120.96%
Sep 30, 2024 -392.45%
Jun 30, 2024 -179.03%
Mar 31, 2024 -498.84%
Dec 31, 2023 -291.44%
Sep 30, 2023 -287.35%
Jun 30, 2023 -212.04%
Mar 31, 2023 -36.05%
Dec 31, 2022 19.30%
Sep 30, 2022 -7.14%
Jun 30, 2022 -18.06%
Mar 31, 2022 -38.22%